SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-024942
Filing Date
2021-05-06
Accepted
2021-05-06 16:05:59
Documents
84
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q pbyi-10q_20210331.htm   iXBRL 10-Q 2153392
2 EX-10.1 pbyi-ex101_134.htm EX-10.1 46082
3 EX-10.2 pbyi-ex102_133.htm EX-10.2 359008
4 EX-10.3 pbyi-ex103_132.htm EX-10.3 176982
5 EX-31.1 pbyi-ex311_7.htm EX-31.1 9300
6 EX-31.2 pbyi-ex312_9.htm EX-31.2 9299
7 EX-32.1 pbyi-ex321_8.htm EX-32.1 6261
8 EX-32.2 pbyi-ex322_6.htm EX-32.2 6279
  Complete submission text file 0001564590-21-024942.txt   10408123

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA pbyi-20210331.xsd EX-101.SCH 64561
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE pbyi-20210331_cal.xml EX-101.CAL 72996
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pbyi-20210331_def.xml EX-101.DEF 180899
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE pbyi-20210331_lab.xml EX-101.LAB 522909
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pbyi-20210331_pre.xml EX-101.PRE 385805
14 EXTRACTED XBRL INSTANCE DOCUMENT pbyi-10q_20210331_htm.xml XML 2105349
Mailing Address 10880 WILSHIRE BLVD. SUITE 2150 LOS ANGELES CA 90024
Business Address 10880 WILSHIRE BLVD. SUITE 2150 LOS ANGELES CA 90024 (424) 248-6500
PUMA BIOTECHNOLOGY, INC. (Filer) CIK: 0001401667 (see all company filings)

IRS No.: 770683487 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35703 | Film No.: 21897696
SIC: 2834 Pharmaceutical Preparations